Home › Funds › Norges Bank Investment Management › TEVA
Norges Bank Investment Management position in TEVA
TEVA PHARMACEUTICAL INDS LTD · Health Care
Latest position (Q2 2026)32.30M sh
Reported value held$1.09B
Portfolio Weight0.11%
First reportedQ2 2007
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2007 | 1 | $0 | New |
| Q3 2007 | 1 | $0 | Hold |
| Q3 2008 | 1.68M | $77.09M | New |
| Q4 2022 | 1.11M | $10.15M | Reduce |
| Q4 2023 | 1.38M | $14.38M | Add |
| Q2 2024 | 1.07M | $17.45M | Reduce |
| Q4 2024 | 1.75M | $38.55M | Add |
| Q2 2025 | 1.86M | $31.25M | Add |
| Q4 2025 | 35.18M | $1.10B | Add |
| Q2 2026 | 32.30M | $1.09B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TEVA
- BlackRock Inc 63.89M sh · $2.16B · Q2 2026
- Fidelity Management & Research (FMR) 30.26M sh · $1.03B · Q2 2026
- Capital World Investors 12.54M sh · $424.72M · Q2 2026
- Geode Capital Management 11.61M sh · $391.01M · Q2 2026
- Northern Trust Corp 7.96M sh · $269.58M · Q2 2026
- Wellington Management Group 7.67M sh · $259.90M · Q2 2026
- Morgan Stanley 6.97M sh · $236.10M · Q2 2026
- Goldman Sachs Group 6.13M sh · $207.66M · Q2 2026
- Janus Henderson Group 4.82M sh · $145.08M · Q1 2026
- Citadel Advisors 4.24M sh · $143.75M · Q2 2026
- Bank of America Corp 4.23M sh · $143.23M · Q2 2026